COHR outpaces SYM with surging AI-driven demand, strong earnings beats and a more attractive valuation profile.

CVX's expanded Venezuela license can revive exports, reshape U.S. oil strategy and give the company a rare edge amid ongoing sanctions uncertainty.

Alphabet's 64.7% stock surge tops the Magnificent 7, fueled by AI-driven gains in search and cloud despite valuation concerns.

Philadelphia, Pennsylvania--(Newsfile Corp. - January 8, 2026) - National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against Skye Bioscience, Inc. (NASDAQ: SKYE) ("Skye" or the "Company") on behalf of investors who purchased or otherwise acquired Skye securities during the period of November 4, 2024 through October 3, 2025 (the "Class Period"), inclusive. Investor Deadline: Investors who purchased Skye securities during the Class Period may, no later than January 16, 2026, seek to be appointed as a lead plaintiff representative of the class.

Novo Nordisk: My Top Pick For 2026

RIG's improving balance sheet and strong backlog support stability, but high debt and offshore cycle risks justify a cautious hold on the stock.

Equity LifeStyle Properties and Veris Residential offer upside as residential REITs battle supply pressure but benefit from steady renting demand.

Cracker Barrel (CBRL) reported earnings 30 days ago. What's next for the stock?

G-III Apparel (GIII) reported earnings 30 days ago. What's next for the stock?

Casey's (CASY) reported earnings 30 days ago. What's next for the stock?

Dave & Buster's (PLAY) reported earnings 30 days ago. What's next for the stock?

SAN DIEGO, Jan. 8, 2026 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Freeport-McMoRan Inc. (NYSE: FCX) publicly traded securities between February 15, 2022 and September 24, 2025, both dates inclusive (the "Class Period"), have until Monday, January 12, 2026 to seek appointment as lead plaintiff of the Freeport-McMoRan class action lawsuit. Captioned Reed v.

Nvidia is now requiring its customers in China to pay upfront in full for its H200 AI chips even as approval Stateside and from Beijing remains uncertain, Reuters reported, citing anonymous sources.

Constellation Brands Inc (NYSE:STZ) shares added more than 4% after the global alcohol producer and marketer's fiscal third quarter earnings topped analyst expectations despite declines in sales and operating income. The company posted net sales of $2.22 billion, down 10% from the prior year, while comparable net sales fell 2%.

Petco Health And Wellness Company, Inc. (WOOF) Q3 2025 Earnings Call Transcript

Precious metals dipped Thursday as the commodity index rebalancing kicked off, with traders saying the largest impacts could be felt in silver and cocoa.

Chipotle shares climb nearly 16% in a month as execution improvements and expansion lift sentiment. Yet, valuation and consumer pressures temper upside.

Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.

Kratos Defense & Security Solutions, Inc. is riding a wave of defense sector momentum, driven by surging demand for drones and geopolitical tensions. KTOS forecasts robust organic revenue growth: 14–15% for 2025, 15–20% for 2026, and 18–23% for 2027, underpinned by major U.S. and international programs. Despite strong top line growth, KTOS remains unprofitable, with persistent cash burn and margin pressures from fixed-price contracts and heavy capital investment.

Burlington Stores, Inc. (BURL) Q3 2025 Earnings Call Transcript